Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $546.17 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Change Healthcare Technologies, LLC | $220.31 | 1 | $0 (2017) |
| Genentech USA, Inc. | $132.63 | 1 | $0 (2019) |
| Progenics Pharmaceuticals, Inc. | $104.73 | 1 | $0 (2022) |
| Incyte Corporation | $20.27 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $15.84 | 1 | $0 (2019) |
| Secura Bio, Inc. | $13.30 | 1 | $0 (2020) |
| Janssen Biotech, Inc. | $13.23 | 1 | $0 (2019) |
| Puma Biotechnology, Inc. | $13.18 | 1 | $0 (2019) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $12.68 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $104.73 | 1 | Progenics Pharmaceuticals, Inc. ($104.73) |
| 2020 | $33.57 | 2 | Incyte Corporation ($20.27) |
| 2019 | $174.88 | 4 | Genentech USA, Inc. ($132.63) |
| 2018 | $12.68 | 1 | NOVARTIS PHARMACEUTICALS CORPORATION ($12.68) |
| 2017 | $220.31 | 1 | Change Healthcare Technologies, LLC ($220.31) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2022 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $104.73 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 01/20/2020 | Secura Bio, Inc. | Farydak (Drug) | Food and Beverage | Cash or cash equivalent | $13.30 | General |
| Category: Oral Oncologic | ||||||
| 01/13/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $20.27 | General |
| Category: Hematology/Oncology | ||||||
| 12/04/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Oncology | ||||||
| 09/23/2019 | Janssen Biotech, Inc. | Balversa (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Oncology | ||||||
| 06/20/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $132.63 | General |
| 04/15/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Oncology | ||||||
| 09/17/2018 | NOVARTIS PHARMACEUTICALS CORPORATION | MEKINIST (Drug), TAFINLAR, VOTRIENT | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: ONCOLOGY | ||||||
| 11/28/2017 | Change Healthcare Technologies, LLC | McKesson Radiology (Device) | Food and Beverage | Cash or cash equivalent | $220.31 | General |
| Category: Radiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 3,150 | 4,461 | $473,445 | $144,113 |
| 2022 | 12 | 3,309 | 4,378 | $497,321 | $159,813 |
| 2021 | 6 | 450 | 454 | $57,110 | $17,208 |
| 2020 | 12 | 1,874 | 1,884 | $351,906 | $63,817 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 565 | 565 | $132,881 | $45,815 | 34.5% |
| 77067 | Screening mammography | Facility | 2023 | 681 | 681 | $79,598 | $24,109 | 30.3% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 553 | 553 | $56,086 | $22,069 | 39.3% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 680 | 680 | $53,750 | $19,131 | 35.6% |
| 76641 | Complete ultrasound scan of 1 breast | Office | 2023 | 135 | 136 | $66,600 | $13,365 | 20.1% |
| 77049 | Mri scan of both breasts | Office | 2023 | 18 | 18 | $18,000 | $4,657 | 25.9% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2023 | 148 | 151 | $11,731 | $2,879 | 24.5% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2023 | 100 | 102 | $12,528 | $2,489 | 19.9% |
| 77065 | Diagnostic mammography of 1 breast | Office | 2023 | 31 | 31 | $9,606 | $2,412 | 25.1% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2023 | 60 | 60 | $8,880 | $1,778 | 20.0% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2023 | 53 | 55 | $5,586 | $1,248 | 22.3% |
| 76642 | Limited ultrasound scan of 1 breast | Office | 2023 | 22 | 22 | $4,565 | $998.38 | 21.9% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2023 | 17 | 17 | $4,250 | $966.62 | 22.7% |
| 76982 | Ultrasound scan of growth for measuring elasticity, first growth | Office | 2023 | 13 | 13 | $3,900 | $866.19 | 22.2% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 2023 | 23 | 23 | $2,926 | $766.14 | 26.2% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 17 | 1,320 | $1,980 | $335.29 | 16.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 17 | $204.00 | $142.80 | 70.0% |
| 82565 | Blood creatinine level | Office | 2023 | 17 | 17 | $374.00 | $85.34 | 22.8% |
| 77067 | Screening mammography | Office | 2022 | 723 | 723 | $175,363 | $58,515 | 33.4% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 708 | 708 | $72,533 | $28,451 | 39.2% |
| 77067 | Screening mammography | Facility | 2022 | 660 | 660 | $74,214 | $23,748 | 32.0% |
| 77063 | Screening 3d breast mammography | Facility | 2022 | 666 | 668 | $49,666 | $19,268 | 38.8% |
| 76641 | Complete ultrasound scan of 1 breast | Office | 2022 | 74 | 118 | $35,408 | $9,130 | 25.8% |
| 77049 | Mri scan of both breasts | Office | 2022 | 12 | 12 | $12,168 | $3,036 | 25.0% |
| 77065 | Diagnostic mammography of 1 breast | Office | 2022 | 36 | 37 | $13,965 | $2,867 | 20.5% |
About Dr. Meredith Collins, D.O
Dr. Meredith Collins, D.O is a Diagnostic Radiology healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2012. The National Provider Identifier (NPI) number assigned to this provider is 1104189745.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Meredith Collins, D.O has received a total of $546.17 in payments from pharmaceutical and medical device companies, with $104.73 received in 2022. These payments were reported across 9 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($546.17).
As a Medicare-enrolled provider, Collins has provided services to 8,783 Medicare beneficiaries, totaling 11,177 services with total Medicare billing of $384,951. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Diagnostic Radiology, Diagnostic Radiology
- Location Greenville, NC
- Active Since 06/19/2012
- Last Updated 01/13/2026
- Taxonomy Code 2085R0202X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104189745
Products in Payments
- McKesson Radiology (Device) $220.31
- PYLARIFY (Drug) $104.73
- JAKAFI (Drug) $20.27
- TAGRISSO (Drug) $15.84
- Farydak (Drug) $13.30
- Balversa (Drug) $13.23
- Nerlynx (Drug) $13.18
- MEKINIST (Drug) $12.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Greenville
Aquilla Turk, Md, MD
Diagnostic Radiology — Payments: $1.6M
Mohammad Chaudry, M.d, M.D
Diagnostic Radiology — Payments: $1.1M
Bruce Schroeder, Md, MD
Diagnostic Radiology — Payments: $189,967
Aron Devane, Md, MD
Diagnostic Radiology — Payments: $128,163
Dr. Michael Ludkowski, M.d, M.D
Diagnostic Radiology — Payments: $14,839
Matthew Gossage, M.d, M.D
Diagnostic Radiology — Payments: $10,726